Diane Wiser
Senior Vice President of Corporate Affairs
Replay available
Cytokinetics, Incorporated (CYTK) Q3 2025 Earnings Call
Cytokinetics, Incorporated (NASDAQ: CYTK) Q3 2025 earnings conference call, held 2025-11-05. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Robert Blum
President and Chief Executive Officer
Andrew Kalos
Executive Vice President and Chief Commercial Officer
Fatih Malik
Executive Vice President of Research and Development
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Cytokinetics, Incorporated.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.096 and welcome to the Cytokinetics Q3 2025 Earnings Conference 00:00:05.096 -- 00:00:10.621 Call. This call is being recorded and all participants are in a listen-only mode. 00:00:10.621 -- 00:00:14.004 After the speaker's remarks, we will open the call to questions. 00:00:14.004 -- 00:00:17.568 We will allow for one question per participant. 00:00:17.568 -- 00:00:21.351 If you would like to ask a question during that time, simply press the star followed 00:00:21.351 -- 00:00:24.294 by the number one on your telephone keypad. 00:00:24.294 -- 00:00:29.339 If you would like to withdraw your question, press star one again once 00:00:29.339 -- 00:00:34.530 more. I would now like to turn the call over to Diane Wiser, Cytokinetics 00:00:34.530 -- 00:00:37.133 Senior Vice President of Corporate Affairs. 00:00:37.133 -- 00:00:39.475 Please go ahead. 00:00:39.475 -- 00:00:42.097 Good afternoon, and thanks for joining us on the call today. 00:00:42.097 -- 00:00:47.101 Robert Blum, President and Chief Executive Officer, will begin with an overview of 00:00:47.101 -- 00:00:52.106 the quarter and recent developments. Andrew Kalos, EVP and Chief Commercial 00:00:52.106 -- 00:00:56.790 Officer, will address commercial readiness activities for Affy Campton. 00:00:56.790 -- 00:01:01.982 Fatty Malik, EVP of R&D, will provide updates related to the clinical development 00:01:01.982 -- 00:01:06.026 program and medical affairs activities for Affy Campton. 00:01:06.026 -- 00:01:11.071 Stuart Kupfer, SVP and Chief Medical Officer, will provide updates on the clinical 00:01:11.071 -- 00:01:15.395 development program for Omicampton McCarble and Eula Campton. 00:01:15.395 -- 00:01:20.420 Sung Lee, EVP and Chief Financial Officer, will provide a financial overv...